Quantitative assessment of CD79B depletion as a biomarker of accelerated B cell progenitor aging
Stem Cell Research · 2026-08 · 94 · 103993
DOI: 10.1016/j.scr.2026.103993 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Research, 2026-08. Verfasst von Silvia Vicenzi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Regenerative Medicine, Department of Medicine, University of California San Diego, La Jolla, CA 92037 USA; Moores Cancer Center, Universi…. Hauptthemen laut MEDLINE: CD79 Antigens, Aging, Cellular Senescence, B-Lymphocytes. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Eye Institute, American Society of Hematology.
Abstract (Originalsprache)
We previously demonstrated that age-related dysfunction in lipid synthesis pathways is associated with impaired B cell progenitor development in mice and humans. Here, we describe an optimized protocol for the quantification of CD79B, a novel biomarker of accelerated aging identified in our multi-omics immune aging study. Flow cytometric analyses of immune cell subpopulations revealed selective depletion of CD19+CD79B+ lymphoid progenitors in bone marrow from aged mice and accelerated aging models, phenocopying advanced physiological aging in humans. Thus, this detailed protocol provides a validated platform to interrogate novel biomarkers of hematopoietic stem and progenitor cell dysfunction associated with systemic aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Regenerative Medicine, Department of Medicine, University of California San Diego, La Jolla, CA 92037 USA; Moores Cancer Center, University of California San Diego, La Jolla, CA 92037 USA.
- Center for Translational Vision Research, Departments of Physiology and Biophysics and Department of Ophthalmology, University of California, Irvine, CA 92617 USA.
- Division of Regenerative Medicine, Department of Medicine, University of California San Diego, La Jolla, CA 92037 USA; Moores Cancer Center, University of California San Diego, La Jolla, CA 92037 USA; Sanford Stem Cell…
Förderung
- NCI NIH HHS
- National Eye Institute
- American Society of Hematology
- University of California, Irvine
- California Institute for Regenerative Medicine
- Blood Cancer United
- National Institutes of Health National Cancer Institute
- University of California, San Diego
Zitieren
APA
Vicenzi, S., Kim, H., Farnan, R., Skowronska-Krawczyk, D., & Crews, L. A. (2026). Quantitative assessment of CD79B depletion as a biomarker of accelerated B cell progenitor aging. Stem Cell Research, 94, 103993. https://doi.org/10.1016/j.scr.2026.103993
Vancouver
Vicenzi S, Kim H, Farnan R, Skowronska-Krawczyk D, Crews LA. Quantitative assessment of CD79B depletion as a biomarker of accelerated B cell progenitor aging. Stem Cell Research. 2026;94:103993. doi:10.1016/j.scr.2026.103993
BibTeX
@article{Vicenzi2026,
author = {Vicenzi, Silvia and Kim, Hangil and Farnan, Rosslyn and Skowronska-Krawczyk, Dorota and Crews, Leslie A},
title = {Quantitative assessment of CD79B depletion as a biomarker of accelerated B cell progenitor aging},
journal = {Stem Cell Research},
year = {2026},
volume = {94},
pages = {103993},
doi = {10.1016/j.scr.2026.103993}
}
EUVIMED